dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with vasoactive intestinal peptide in 1 studies
| Studies (dibutyryl cyclic-3',5'-cytidine monophosphate) | Trials (dibutyryl cyclic-3',5'-cytidine monophosphate) | Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 72 | 0 | 18 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dartt, DA; Funaki, C; Hodges, RR | 1 |
1 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and vasoactive intestinal peptide
| Article | Year |
|---|---|
Role of cAMP inhibition of p44/p42 mitogen-activated protein kinase in potentiation of protein secretion in rat lacrimal gland.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Animals; Blotting, Western; Calcium; Carbachol; Cholinergic Agonists; Colforsin; Cyclic AMP; Cyclic CMP; Diterpenes; Dose-Response Relationship, Drug; Enzyme Activators; Epidermal Growth Factor; In Vitro Techniques; Lacrimal Apparatus; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peroxidases; Phenylephrine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Vasoactive Intestinal Peptide | 2007 |